ENvue Medical, Inc.
No SEC Form 4 filings for $FEED in the last 30 days.
See all $FEED insider activity →ENvue Medical (FEED) announced a 1-for-12 reverse stock split, effective September 1, 2026. Outstanding shares will reduce from 11.08 million to 923,718. The split was approved by the board and does not affect shareholders' ownership or voting power. FEED is trading down 7.04% at $0.34.
ENvue Medical, Inc. (FEED) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07. Submission of Matters to a Vote of Security Holders. On August 14, 2026, ENvue Medical, Inc. (the “ Company ”) held a special meeting of stockholders (the “ Special Meeting ”). The final voting results of the Special Meeting are set forth below. Stockholders voted on t
ENvue Medical, Inc. (FEED) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Committed Equity Facility of up to $50 million On August 12, 2026, ENvue Medical, Inc. (the “Company”) entered into a Common Shares Purchase Agreement (the “Purchase Agreement”), with an institutional investor (the “Investor”)
Over the past 7 days, alphai's AI scored 2 news stories mentioning FEED (ENvue Medical, Inc.). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.
Recent FEED coverage spans corporate actions, financial news and technology.
The reverse split reduces share count and may improve price perception, affecting liquidity and short‑term trading.
Shareholder approval clears the way for a board-determined reverse split, which can affect liquidity, per-share price optics, and near-term trading dynamics.
The 8-K discloses a structured equity issuance facility that can create near-term dilution over time, depending on how often the company issues VWAP purchase notices.
Board refresh may improve investor confidence and oversight around ENvue’s navigation and AI platforms, but it is not a direct operational or financial catalyst.
Board turnover and committee reassignments can shift governance oversight, but the filing provides no operational or financial guidance changes.
alphai scores every news story that mentions FEED with an AI model for sentiment and relevance, and aggregates insider trades from ENvue Medical, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
ENvue Medical (FEED) announced a 1-for-12 reverse stock split, effective September 1, 2026. Outstanding shares will reduce from 11.08 million to 923,718. The split was approved by the board and does not affect shareholders' ownership or voting power. FEED is trading down 7.04% at $0.34.
1 min readENvue Medical, Inc. (FEED) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07. Submission of Matters to a Vote of Security Holders. On August 14, 2026, ENvue Medical, Inc. (the “ Company ”) held a special meeting of stockholders (the “ Special Meeting ”). The final voting results of the Special Meeting are set forth below. Stockholders voted on t
3 min readENvue Medical, Inc. (FEED) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Committed Equity Facility of up to $50 million On August 12, 2026, ENvue Medical, Inc. (the “Company”) entered into a Common Shares Purchase Agreement (the “Purchase Agreement”), with an institutional investor (the “Investor”)
4 min readENvue Medical (NASDAQ: FEED) said Zeev Rotstein, M.D. was appointed Chairman of the Board, replacing David Johnson, who and Nino Pionati are departing. ENvue also added Zvi Joseph and Lior Buchman as directors. The company cited Joseph’s AI governance background at Amdocs and Buchman’s $320 million in executed financings and M&A.
3 min readENvue Medical, Inc. (FEED) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001326706 0001326706 2026-07-14 2026-07-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Repor
2 min readENvue Medical (NASDAQ: FEED) said it developed and demonstrated a first prototype of ENvue Drive, a robotic-assisted, AI-integrated tool within its electromagnetic navigation platform. The prototype combined Ask Oscar AI navigation with robotic tube advancement in a simulated bedside enteral procedure. ENvue Drive is investigational and not FDA-cleared.
3 min readGlibert Christian Michael sold 210,000 shares of ENvue Medical, Inc. (FEED) at $0.69 ($0.14M total) on 2026-06-22.
2 min readENvue Medical (NASDAQ: FEED) has registered the resale of up to 6,000,768 shares of common stock, which are issuable upon the conversion of Series H Convertible Preferred Stock. The company will not receive any proceeds from these resales, as they are for the benefit of a selling stockholder. This registration could lead to significant dilution, representing approximately 53.4% of outstanding shares, and may impact the company's stock price and compliance with Nasdaq listing requirements.
3 min readENvue Medical has renewed a three-year purchasing agreement with a Group Purchasing Organization representing one of the largest non-profit health systems in the U.S., encompassing over 90 hospitals across 17 states. This renewal simplifies the procurement process for its ENvue Navigation Platform, allowing participating hospitals to adopt the technology without individual facility-level approvals. The agreement aims to increase utilization and expand ENvue's installed base within the extensive network through 2028.
3 min readENvue Medical has renewed a three-year purchasing agreement with a Group Purchasing Organization for a major U.S. health system, covering over 90 hospitals across 17 states. This agreement streamlines access to ENvue's Navigation Platform, removing the need for individual facility approvals and providing a strong commercial foundation for the company. The renewal signifies confidence in ENvue's technology and is expected to drive broader utilization within the network.
3 min read
